Warfarin Sodium
Product Images NDC 70934-587

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 70934-587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 587 30 Master Bottle Label Approval Rev A 02 20)

Label (70934 587 30 Master Bottle Label Approval   Rev A 02 20)
Warfarin Sodium Tablets, USP 3 mg blister pack label containing 30 tablets. The label specifies Rx only, dosage instructions to see package insert, and storage conditions of 20°-25°C with allowable excursions. Manufactured by Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label includes lot number and expiration date fields, along with warnings for serious bleeding risks and to keep the product out of reach of children.*
FDA Label Image

Chemical Structure (Warfarin 1)

Chemical Structure (Warfarin 1)
Chemical structure of Warfarin Sodium, showing the molecular arrangement of atoms and bonds characteristic to this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.